Viewing Study NCT06134193


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-02 @ 8:11 PM
Study NCT ID: NCT06134193
Status: UNKNOWN
Last Update Posted: 2023-11-18
First Post: 2023-11-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module